Transrectal ultrasound imaging of the prostate: Review and perspectives of recent developments

Prostate Cancer and Prostatic Diseases

Volumn 2, Issue 5-6, 1999, Pages 241-252

  Sedelaar, J P M ^a   De La Rosette, J J M C H ^a   Beerlage, H P ^a   Wijkstra, H ^a   Debruyne, F M J ^a   Aarnink, R G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Contrast enhancement; Diagnosis; Doppler imaging; Prostate; Treatment monitoring; Ultrasound

Indexed keywords

CANCER DIAGNOSIS; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; GRAY SCALE ECHOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND TRANSDUCER; VOLUMETRY;

EID: 0033512011     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500326     Document Type: Review

References (89)

1. Brawley OW. Prostate carcinoma incidence and patient mortality: the effect of screening and early detection. Cancer 1997; 80: 1857-1863.
2. Littrup PI, Sparschu R. Transrectal ultrasound and prostate cancer risks. Cancer 1995; 75: 1805-1813.
3. Garnick MB, Fair WR. Prostatic cancer emerging concepts. Part I Ann Intern Med 1996; 125: 118-125.
4. Littrup PJ et al. Cost-effective prostate cancer detection: reduction of low-yield biopsies. Cancer 1994a; 74: 3146-3158.
5. Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the US. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83: 1679-1684.
6. Watanabe H. History and applications of transrectal ultrasonography of the prostate. Urol Clin N Amer 1989; 16: 617-622.
7. Watanabe H et al. Development and application of new equipment for transrectal ultrasonography. J Clin Ultrasound 1974; 2: 91-98.
8. Beerlage HP, De Reijke TM, De la Rosette JJMCH. Considerations regarding prostate biopsies. Eur Urol 1998; 34: 303-312.
9. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998; 159: 471-476.
10. Svctec D et al. Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. J Urol 1998; 15: 1606-1608.
11. Aarnink RG et al. Transrectal ultrasound of the prostate: Innovations and future applications. J Urol 1998; 159: 1568-1579.
12. Onder AU et al. Impact of transition zone biopsies in detection and evaluation of prostate cancer. Eur Urol 1998; 33: 542-548.
13. Renfer RP, Schwob D, Thompson IA, Optenberg S. Is ultrasound guidance necessary for transrectal prostate biopsy? J Urol 1995; 154: 1390-1391.
14. Giesen RJB et al. Computer analysis of transrectal ultrasound images of the prostate for the detection of carcinoma: a prospective study in radical prostatectomy specimens. J Urol 1995; 154: 1397-1400.
15. Chodak GW et al. Comparison of digital rectal examination and transrectal ultrasonography for the diagnosis of prostatic cancer. J Urol 1986; 135: 951-954.
16. Lee F et al. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989; 170: 609-615.
17. Chodak GW, Schoenberg HW. Progress and problems in screening for carcinoma of the prostate. World J Surg 1989; 13: 60-64.
18. Lee F, Torp-Pedersen ST, McLeary RD. Diagnosis of prostate cancer by transrectal ultrasound. Urol Clin North Am 1989; 16: 663-673.
19. Terris EK, Freiha FS, McNeal JE, Stamey TA. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer. J Urol 1991; 146: 78-830.
20. Oyen R et al. The significance of focal hypoechoic lesions in the peripheral zone of the prostate. J Belge Radiol 1995; 78: 356-358.
21. Sibley RI, Sibley AF. Correlation of digital rectal examination, prostate specific antigen, and transrectal ultrasound in prostate carcinoma in African Americans. J Natl Med Assoc 1997; 89: 318-323.
22. Ellis WI, Brawer MK. The significance of isoechoic prostatic carcinoma. J Urol 1994; 152: 2304-2307.
23. Garber SJ et al. Systemic transrectal ultrasound-guided biopsy of the prostate. J Can Assoc Radiol 1994; 45: 387-390.
24. Hodge KK, McNeal SE, Terris MK, Stamey TA. Random systemic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71-73.
25. Hammerer P, Huland H. Systemic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 1994; 151: 99-102.
26. Norberg M et al. The sextant protocol for ultrasound guided biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562-566.
27. Eskew LA, Bare RL, McCullough DL. Systemic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199-203.
28. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol 1997; 151: 1571-1574.
29. Aarnink RG, Wijkstra H. Aspects of imaging in the assessment and follow-up of Benign Prostatic Hyperplasia. Curr Opin Urol 1999; 9: 21-29.
30. Aarnink RG et al. Diagnosis of prostate cancer in patients with prostate related problems in urological clinic: current status and future developments. Tijdschr Gerontol Geriatr 1997; 28: 264-271.
31. Lee F et al. Hypoechoic lesions of the prostate: Clinical relevance of tumour size, digital rectal examination and prostate specific antigen. Radiology 1989; 170: 29-32.
32. Bangma CH, Kranse R, Blijenberg BO, Schröder FH. The value of screening test in the detection of prostate cancer 1. Results of a retrospective evaluation of 1726 men. Urology 1995; 46: 773-778.
33. Huynen AL et al. Analysis of ultrasonographic prostate images for the detection of prostatic carcinoma: the automated urologic diagnositic expert system. Ultrasound Med Biol 1994; 20: 1-10.
34. Giesen RJ et al. Ultrasonic computer imaging of the prostate: correlation between longitudinal and transverse texture descriptions. Eur J Ultrasound 1995; 2: 145-149.
35. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78: 940-944.
36. Folkman J, Cotran R. Relation of vascular proliferation to tumour growth. Int Rev Exp Pathol 1976; 16: 207-248.
37. Hall MC et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiation, Urology 1994; 44: 869-875.
38. Bostwick DG, Iczkowiski KA. Microvessel density in prostate cancer: prognostic and therapeutic utility. Semin Urol Oncol 1998; 16: 118-123.
39. Fornage BD. Transrectal duplex sonography of prostatic carcinoma: preliminary experience (abstr). Radiology 1989; 173: 81.
40. Ismail M, Gomella LG, Alexander AA. Color Doppler sonography of the prostate. Tech Urol 1997; 3(3): 140-146.
41. Kelly IMG, Lees WR, Rickards D. Prostate cancer and the role of Colour Doppler US. Radiology 1993; 189: 153-156.
42. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with Colour Doppler sonography with histologic correlation of each biopsy site. Radiology 1995; 195: 86-90.
43. Cho JY, Kim SH, Lee SE. Diffuse prostatic lesions: role of color Doppler ultrasonography. J Ultrasound Med 1998; 17(5): 283-287.
44. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results and potential applications of color Doppler US scanning. Radiology 1993; 186: 509-513.
45. Cornud F et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997; 49(5): 709-715.
46. Lavoipierre AM et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR 1998; 171: 205-210.
47. Ismail M et al. Color Doppler imaging in predicting the biology behaviour of prostate cancer: correlation with disease-free survival. Urology 1997; 50(6): 906-912.
48. Bude RO, Rubin JM. Power Doppler sonography. Radiology 1996; 200: 21-23.
49. Rubin JM et al. Power Doppler US: a potentially useful alternative to mean frequency based colour Doppler US. Radiology 1994; 190: 853-856.
50. Rubin JM, Adler RS, Fowlkes JB. Fractional moving blood volume: estimation with power Doppler US. Radiology 1995; 197: 183-190.
51. Adler RS et al. Ultrasonic estimation of tissue perfusion: a stochastic approach. Ultrasound Med Biol 1995; 21: 493-500.
52. Sakarya ME et al. The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br J Urol 1998; 82: 386-388.
53. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Rad 1968; 3: 356-366.
54. Mattrey RF, Steinbach GC. Ultrasound contrast agents: state of the art. Invest Radiol 1991; 26: 5-11.
55. Mattrey RF et al. Perfluorochemicals as US contrast agents for tumour imaging and hepatosplenography: preliminary clinical results. Radiology 1987; 163: 339-343.
56. Ragde H, Kenny GM, Murphy GP, Landin K. Transrectale ultrasound microbubble contrast angiography of the prostate. Prostate 1997; 32: 279-283.
57. Cosgrove D. Ultrasound contrast enhancement of tumours. Clin Rad 1996; 51(Suppl): 44-49.
58. Candiani F. The latest in ultrasound: three-dimensional imaging. Part I. Eur J Radiol 1998; 27: S178-S182.
59. Campani R, Bottinelli O, Calliada F, Coscia D. The latest in ultrasound: three-dimensional imaging. Part II. Eur J Radiol 1998; 27: S183-S187
60. Bogers JA et al. Contrast-enhanced 3D power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54(1): 97-104.
61. Aarnink RG et al. Contrast angiosonography: a technology to improve Doppler ultrasound examinations of the prostate. Eur Urol 1999; 35: 9-20.
62. Burns PA. Harmonic imaging with ultrasound contrast agents. Clin Rad 1996; 51 (Suppl 1): 50-55.
63. Calliada F et al. Ultrasound contrast agents: basic principles. Eur J Radiol 1998; 27: S157-S160
64. Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurements. Ultrasound Med Biol 1993; 19: 567-579.
65. Spencer KT et al. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol 1998; 82: 794-799.
66. Kono Y et al. Grey-scale second harmonic imaging of the liver with galactose-based to microbubbles. Invest Radiol 1997; 32: 120-125.
67. Bauer A et al. Wideband harmonic imaging with Levovist. Preliminary studies (abstract C 10.7). Eur J Ultrasound 1997; 6: S34.
68. Hope Simpson D, Ting Chin C, Burns PN. Pulse inversion Doppler: a new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelect Freq Contr 1999; 46(2): 372-382.
69. Maresca G et al. New prospects for ultrasound contrast agents. Eur J Radiol 1998; 27: S171-S178.
70. Becher H, Tiemann K. Second harmonic imaging with Levovist®: initial clinical experience. European symposium on ultrasound contrast, Rotterdam, The Netherlands, abstract 24, January 23-24, 1997.
71. Kremkau FW et al. The American Institute of Ultrasound in Medicine and the society of Radiologists in Ultrasound - future directions in diagnostic US. Radiology 1998; 209(2): 305-311.
72. D'Ancona FC et al. Transurethral resection of the prostate vs. high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998; 81: 259-264.
73. Hill CR, Ter Haar GR. Review article: high intensity focused ultrasound - potential for cancer treatment. Br J Radiol 1995; 65: 1296-1303.
74. De Wildt MI, Debruyne FM, de la Rosette JJ. High energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatie obstruction. Urology 1996; 48: 416-423.
75. De Wildt MJ et al. A 12-month study of the placebo effect in transurethral microwave thermotherapy. Br J Urol 1996; 77: 221-227.
76. D'Ancona FC, Francisca BA, Debruyne FM, de la Rosette JJ. High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms. J Endourol 1997; 11: 285-289.
77. Beerlage HP et al. High Intensity Focused Ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy; results of a prospective study. Prostate 1999; 39(1): 41-46.
78. Sedelaar JPM et al. The application of 3D contrast enhanced ultrasound to measure volume of affected tissue following HIFU treatment for localized prostate cancer. Eur Urol 1999. (Accepted for publication).
79. Parker KJ et al. Vibration sonoelastography and the detectability of lesions. Ultrasound in Med & Biol 1998; 24(9): 1437-1447.
80. Sarvazyan AP et al. Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics. Ultrasound in Med & Biol 1998; 24(9): 1419-1435.
81. Zong X, Laine AF, Geiser EA. Speckle reduction and contrast enhancement of echocardio grams via multiscale non-linear processing. IEEE Trans Med Imag 1998; 17(4): 532-540.
82. Aamink RG et al. Edge detection in prostatic ultrasound images using integrated edge maps. Ultrasonics 1998; 36(1-5): 635-612.
83. Gudmundsson M, El-Kwae EA, Kabuka MR. Edge detection in medical images using a genetic algorithm. IEEE Trans Med Imag 1998; 17(3): 469-474.
84. Madersbacher S, Haidinger G, Temml C, Schmidbauer CP. Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2096 men. Eur Urol 1998; 32: 136-141.
85. Jacobsen SJ et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158: 481-487.
86. Brawley OW. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer 1997; 80: 1857-1863.
87. Smart CR. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology and end results program. Cancer 1997; 80: 1835-1844.
88. Whittingham TA. New and future developments in ultrasonic imaging. Br J Rad 1997; 70: S119-S132.
89. Rizzatto G. Ultrasound transducers. Eur J Radiol 1998; 27: S188-S195.